The visual system in Parkinson's disease.
Bodis-Wollner
I
I
Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029.
Tagliati
M
M
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D015350:Contrast Sensitivity / Q000187:drug effects / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D004569:Electroencephalography / Q000187:drug effects / Q000295:instrumentation; D004596:Electroretinography / Q000187:drug effects / Q000295:instrumentation; D005583:Fourier Analysis; D006801:Humans; D008252:Macaca fascicularis; D008253:Macaca mulatta; D009039:Motion Perception / Q000187:drug effects / Q000502:physiology; D009949:Orientation / Q000187:drug effects / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology*; D010364:Pattern Recognition, Visual / Q000187:drug effects / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000502:physiology; D012160:Retina / Q000187:drug effects / Q000503:physiopathology*; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation; D013469:Sulpiride / Q000494:pharmacology
D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D013469:Sulpiride; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine